• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Annual Changes to the Nasdaq-100 Index®

    12/12/25 8:00:00 PM ET
    $ALNY
    $BIIB
    $CDW
    $FER
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ALNY alert in real time by email

    NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (NDX®), which will become effective prior to market open on Monday, December 22, 2025.

    The following six companies will be added to the Index: Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), Ferrovial SE (NASDAQ:FER), Insmed Incorporated (NASDAQ:INSM), Monolithic Power Systems, Inc. (NASDAQ:MPWR), Seagate Technology Holdings plc (NASDAQ:STX), Western Digital Corp. (NASDAQ:WDC).

    The Nasdaq-100 Index is a globally recognized index that tracks the performance of 100 of the largest non-financial companies listed on the Nasdaq Stock Market® encompassing a diverse range of industries and sectors. From technology and retail to healthcare, telecommunications, biotechnology, and media, these companies collectively shape the new 21st century economy. The Nasdaq-100® is reconstituted each year in December, timed to coincide with the quadruple witch expiration Friday of the quarter.

    As of December 2025, the Nasdaq-100 Index underpins more than 200 tracking products with over $600 billion in assets under management globally, including the Invesco QQQ Trust (QQQ®), which seeks to deliver investment results that, before expenses, correspond to the performance of the Nasdaq-100 Index. In addition to QQQ, a range of derivatives and structured instruments, such as futures, options, and other products based on the Nasdaq-100 Index and the Invesco QQQ Trust trade on various exchanges.

    As a result of the reconstitution, the following six companies will be removed from the Index: Biogen Inc. (NASDAQ:BIIB), CDW Corporation (NASDAQ:CDW), GlobalFoundries Inc. (NASDAQ:GFS), Lululemon Athletica Inc. (NASDAQ:LULU), ON Semiconductor Corporation (NASDAQ:ON), The Trade Desk, Inc. (NASDAQ:TTD).

    Information

    For information about the six companies to be added to the Nasdaq-100 Index, please visit the following respective company websites:

    • Alnylam Pharmaceuticals, Inc. – https://www.alnylam.com/
    • Ferrovial SE – https://www.ferrovial.com/
    • Insmed Incorporated – https://insmed.com/
    • Monolithic Power Systems, Inc. – https://www.monolithicpower.com/
    • Seagate Technology Holdings plc – https://www.seagate.com/
    • Western Digital Corp. – https://www.westerndigital.com/



    About Nasdaq Global Indexes

    Nasdaq Global Indexes has been creating innovative, market-leading, transparent indexes since 1971. Today, our index offering spans geographies and asset classes and includes diverse families such as the Dividend and Income (includes Dividend Achievers), Dorsey Wright, Fixed Income (includes BulletShares®), Global Equity, Green Economy, Nordic, and Commodity indexes. We continuously offer new opportunities for financial product sponsors across a wide spectrum of investable products and for asset managers to measure risk and performance. Nasdaq also provides exchange listing, custom index, and design solutions to financial organizations worldwide.

    About Nasdaq

    Nasdaq (NASDAQ:NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. We aspire to deliver world-leading platforms that improve the liquidity, transparency, and integrity of the global economy. Our diverse offering of data, analytics, software, exchange capabilities, and client-centric services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions, and career opportunities, visit us on LinkedIn, on X @Nasdaq, or at www.nasdaq.com

    Nasdaq®, Nasdaq-100 Index®, Nasdaq-100®, NDX®, QQQ®, and Nasdaq Stock Market® are registered trademarks of Nasdaq, Inc. The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. Neither Nasdaq, Inc. nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding Nasdaq-listed companies or Nasdaq proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

    Media Relations Contact Investor Relations Contact
    Name: Maximilian Leitenberger

    Email: [email protected]



     Name: Index Client Services

    Email: [email protected]

       

    NDAQF



    Primary Logo

    Get the next $ALNY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALNY
    $BIIB
    $CDW
    $FER

    CompanyDatePrice TargetRatingAnalyst
    GlobalFoundries Inc.
    $GFS
    12/31/2025$40.00Outperform → Neutral
    Wedbush
    Insmed Incorporated
    $INSM
    12/19/2025$202.00Buy
    Truist
    lululemon athletica inc.
    $LULU
    12/12/2025$170.00Underperform → Hold
    Jefferies
    lululemon athletica inc.
    $LULU
    12/12/2025$200.00 → $215.00Market Perform
    Telsey Advisory Group
    lululemon athletica inc.
    $LULU
    12/10/2025Neutral
    Guggenheim
    Biogen Inc.
    $BIIB
    12/10/2025$143.00Hold → Reduce
    HSBC Securities
    The Trade Desk Inc.
    $TTD
    12/8/2025$50.00 → $40.00Neutral
    Wedbush
    Western Digital Corporation
    $WDC
    12/5/2025$193.00Buy
    China Renaissance
    More analyst ratings

    $ALNY
    $BIIB
    $CDW
    $FER
    SEC Filings

    View All

    SEC Form 6-K filed by Ferrovial SE

    6-K - Ferrovial SE (0001468522) (Filer)

    12/30/25 10:45:36 AM ET
    $FER
    Military/Government/Technical
    Industrials

    SEC Form DEFA14A filed by lululemon athletica inc.

    DEFA14A - lululemon athletica inc. (0001397187) (Filer)

    12/30/25 6:04:37 AM ET
    $LULU
    Apparel
    Consumer Discretionary

    SEC Form DEFA14A filed by lululemon athletica inc.

    DEFA14A - lululemon athletica inc. (0001397187) (Filer)

    12/29/25 5:06:39 PM ET
    $LULU
    Apparel
    Consumer Discretionary

    $ALNY
    $BIIB
    $CDW
    $FER
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Desjardins Clarissa bought $201,694 worth of shares (3,025 units at $66.68) (SEC Form 4)

    4 - INSMED Inc (0001104506) (Issuer)

    5/22/25 5:20:35 PM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Reitan Colleen F bought $10,363 worth of shares (36 units at $287.85), sold $8,383 worth of shares (36 units at $232.86) and was granted 775 shares (SEC Form 4)

    4 - ALNYLAM PHARMACEUTICALS, INC. (0001178670) (Issuer)

    5/12/25 4:05:00 PM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Dorsa Caroline bought $151,559 worth of shares (1,235 units at $122.72), increasing direct ownership by 5% to 27,842 units (SEC Form 4)

    4 - BIOGEN INC. (0000875045) (Issuer)

    5/5/25 4:17:10 PM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ALNY
    $BIIB
    $CDW
    $FER
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    GlobalFoundries downgraded by Wedbush with a new price target

    Wedbush downgraded GlobalFoundries from Outperform to Neutral and set a new price target of $40.00

    12/31/25 7:23:24 AM ET
    $GFS
    Semiconductors
    Technology

    Truist resumed coverage on Insmed with a new price target

    Truist resumed coverage of Insmed with a rating of Buy and set a new price target of $202.00

    12/19/25 8:48:21 AM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    lululemon athletica upgraded by Jefferies with a new price target

    Jefferies upgraded lululemon athletica from Underperform to Hold and set a new price target of $170.00

    12/12/25 8:37:05 AM ET
    $LULU
    Apparel
    Consumer Discretionary

    $ALNY
    $BIIB
    $CDW
    $FER
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP & General Counsel Tseng Saria gifted 1,000 shares and received a gift of 1,000 shares, decreasing direct ownership by 0.60% to 166,331 units (SEC Form 4)

    4 - MONOLITHIC POWER SYSTEMS INC (0001280452) (Issuer)

    12/30/25 6:08:47 PM ET
    $MPWR
    Semiconductors
    Technology

    Director Morfitt Martha A M gifted 6,500 shares, decreasing direct ownership by 7% to 86,990 units (SEC Form 4)

    4 - lululemon athletica inc. (0001397187) (Issuer)

    12/29/25 8:30:16 PM ET
    $LULU
    Apparel
    Consumer Discretionary

    Officer Locy Peter R covered exercise/tax liability with 139 shares, decreasing direct ownership by 4% to 3,228 units (SEC Form 4)

    4 - CDW Corp (0001402057) (Issuer)

    12/29/25 4:20:19 PM ET
    $CDW
    Retail: Computer Software & Peripheral Equipment
    Technology

    $ALNY
    $BIIB
    $CDW
    $FER
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for VUMERITY issued to BIOGEN INC

    Submission status for BIOGEN INC's drug VUMERITY (ORIG-1) with active ingredient DIROXIMEL FUMARATE has changed to 'Approval' on 09/12/2024. Application Category: NDA, Application Number: 761347, Application Classification: Type 3 - New Dosage Form

    9/16/24 6:52:10 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for VUMERITY issued to BIOGEN INC

    Submission status for BIOGEN INC's drug VUMERITY (SUPPL-17) with active ingredient DIROXIMEL FUMARATE has changed to 'Approval' on 09/11/2024. Application Category: NDA, Application Number: 211855, Application Classification: Manufacturing (CMC)

    9/16/24 6:24:32 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for GIVLAARI issued to ALNYLAM PHARMS INC

    Submission status for ALNYLAM PHARMS INC's drug GIVLAARI (SUPPL-7) with active ingredient GIVOSIRAN SODIUM has changed to 'Approval' on 04/29/2024. Application Category: NDA, Application Number: 212194, Application Classification: Labeling

    4/30/24 1:44:03 PM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALNY
    $BIIB
    $CDW
    $FER
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Insmed To Present at the 44th Annual J.P. Morgan Healthcare Conference

    BRIDGEWATER, N.J., Jan. 2, 2026 /PRNewswire/ -- Insmed Incorporated (NASDAQ:INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the J.P. Morgan 2026 Healthcare Conference in San Francisco, on Monday, January 12, 2026, at 3:00 p.m. PT / 6:00 p.m. ET. This event will be webcast live and can be accessed by visiting the investor relations section of the Company's website at www.insmed.com. Webcasts will be archived for a period of 30 days following the conclusion of the live events. About Insmed Insmed Incorporated is a people-first

    1/2/26 7:00:00 AM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    lululemon Comments on Chip Wilson's Notice to Nominate Director Candidates

    Shareholders Not Required to Take Any Action at this Time lululemon athletica inc. (NASDAQ:LULU) ("lululemon" or the "company") today commented on Chip Wilson's announcement that he has submitted a notice to nominate three director candidates to stand for election to the company's Board at lululemon's 2026 Annual Meeting of Shareholders: The lululemon Board of Directors and leadership team have engaged extensively and in good faith for many years with Mr. Wilson to understand his perspectives and communicate our strategy. In our most recent discussions, Mr. Wilson indicated his intent to nominate directors. In the interest of avoiding a costly and distracting proxy fight, the Board requ

    12/29/25 3:38:00 PM ET
    $LULU
    Apparel
    Consumer Discretionary

    Chip Wilson Nominates Three Independent Director Candidates for Election to the lululemon athletica inc. Board of Directors

    Nominees are Highly Experienced, Proven Creative Leaders that Will Restore Faith in the Board's Ability to Oversee lululemon's Transformation to Create Long-Term Shareholder Value CEO Selection Must Take Place Following Significant Board Change to Be Sure Shareholders Can Trust the Right Decision is Made and the New Leader Can Succeed VANCOUVER, BC, Dec. 29, 2025 /PRNewswire/ -- Chip Wilson, Founder of lululemon athletica inc. (NASDAQ: LULU) ("lululemon" or the "Company") and one of lululemon's largest shareholders, today announced the nomination of three independent and highly qualified director candidates (collectively, the "Candidates") for election to the lululemon Board of Directors (th

    12/29/25 8:30:00 AM ET
    $LULU
    Apparel
    Consumer Discretionary

    $ALNY
    $BIIB
    $CDW
    $FER
    Financials

    Live finance-specific insights

    View All

    Insmed Provides Clinical and Business Update

    —Phase 2b BiRCh Study of Brensocatib in CRSsNP Did Not Meet Primary or Secondary Efficacy Endpoints; Safety Consistent with Previous Studies; Insmed Discontinues CRSsNP Program— —Company Acquires Phase 2 Ready Monoclonal Antibody for Potential Respiratory and Immunological & Inflammatory Indications— BRIDGEWATER, N.J., Dec. 17, 2025 /PRNewswire/ -- Insmed Incorporated (NASDAQ:INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, announced today that the Phase 2b BiRCh study of brensocatib in patients with chronic rhinosinusitis without nasal polyps (CRSsNP) did not meet its pri

    12/17/25 4:01:00 PM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Annual Changes to the Nasdaq-100 Index®

    NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (NDX®), which will become effective prior to market open on Monday, December 22, 2025. The following six companies will be added to the Index: Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), Ferrovial SE (NASDAQ:FER), Insmed Incorporated (NASDAQ:INSM), Monolithic Power Systems, Inc. (NASDAQ:MPWR), Seagate Technology Holdings plc (NASDAQ:STX), Western Digital Corp. (NASDAQ:WDC). The Nasdaq-100 Index is a globally recognized index that tracks the performance of 100 of the largest non-financial companies listed on the Nasdaq Stock Market® encompassi

    12/12/25 8:00:00 PM ET
    $ALNY
    $BIIB
    $CDW
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Retail: Computer Software & Peripheral Equipment

    Ferrovial announces the termination of its existing share repurchase program and the implementation of a new share repurchase program

    AMSTERDAM, Dec. 12, 2025 /PRNewswire/ -- Ferrovial SE ("Ferrovial" or the "Company", Ticker: "FER") announces that it has resolved to terminate, with effect from today's closing of the U.S. stock exchanges, the ongoing buyback program announced to the market on 14 March 2025 and commenced on 2 June 2025 (the "Current Program"). In accordance with applicable regulations, Ferrovial will provide details of the final repurchases of Ferrovial shares under the Current Program, including the total number of shares acquired and the total amount invested under the Current Program.    

    12/12/25 6:57:00 PM ET
    $FER
    Military/Government/Technical
    Industrials

    $ALNY
    $BIIB
    $CDW
    $FER
    Leadership Updates

    Live Leadership Updates

    View All

    Nasdaq Maintains Over a Decade of Listings Leadership in 2025

    Largest Exchange Transfer in History & Biggest IPO of the Year Highest Capital Raised Since 2021 - $46.65 Billion Raised NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) announced today that in 2025 it raised a total of $46.65 billion from new listings, marking the strongest year for capital raise since 2021. In addition, 22 companies transferred their corporate listings to Nasdaq in 2025 including Walmart, the largest exchange transfer in history. Since 2005, companies transferring their listing to Nasdaq have represented more than $4 trillion in total market value. "2025 marked a meaningful resurgence for the public markets. Companies at every stage continue to choose

    12/18/25 7:00:00 AM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Lumentum Appoints Thad Trent to Board of Directors

    Lumentum Holdings Inc. ("Lumentum"), a global leader in optical and photonic technology, today announced the appointment of Thad Trent to the company's Board of Directors, effective immediately. His appointment expands the board membership to nine members. "I am thrilled to welcome Thad to the Lumentum Board," said Penelope Herscher, Chair of Lumentum's Board of Directors. "He brings a wealth of expertise in corporate finance, M&A activity, in-house manufacturing and process efficiency that is mission-critical to our future. I am confident his valuable insights will accelerate the execution of our long-term strategy, helping us drive growth and deliver sustainable shareholder value." "Lum

    12/15/25 4:04:00 PM ET
    $LITE
    $ON
    Telecommunications Equipment
    Telecommunications
    Semiconductors
    Technology

    GlobalFoundries Appoints Sam Franklin as Chief Financial Officer

    MALTA, N.Y., Dec. 10, 2025 (GLOBE NEWSWIRE) -- GlobalFoundries (GF) today announced that its Board of Directors has appointed Sam Franklin as Chief Financial Officer, effective immediately. Mr. Franklin previously served as Senior Vice President of Business Finance & Operations and Investor Relations and recently Interim CFO. "We are delighted to have Sam formally appointed as CFO," said Tim Breen, CEO of GF. "His proven leadership and financial expertise will accelerate GF's momentum and capitalize on the significant opportunities ahead. As we continue to drive profitability and deliver differentiated technologies for the scaling of AI from the data center to the physical world, Sam's ab

    12/10/25 5:30:00 PM ET
    $GFS
    Semiconductors
    Technology

    $ALNY
    $BIIB
    $CDW
    $FER
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by The Trade Desk Inc.

    SC 13G/A - Trade Desk, Inc. (0001671933) (Subject)

    11/14/24 4:42:28 PM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SC 13G/A filed by Insmed Incorporated

    SC 13G/A - INSMED Inc (0001104506) (Subject)

    11/14/24 1:22:37 PM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Western Digital Corporation

    SC 13G/A - WESTERN DIGITAL CORP (0000106040) (Subject)

    11/14/24 1:22:34 PM ET
    $WDC
    Electronic Components
    Technology